Overview
Status
Active
Registry date
2016-10-21
Share capital
5,000.00 PLN
Registered address
ul. Wierzbiny 8, 03-289 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 1 of 4 financial statements was filed late (for 2021, 92 days late).
- 2022not filed
- 202115/10/2022
- 202015/10/2021
- 201928/09/2020
- 201815/07/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2021.
Voivodeship · Mazowieckie24,796 / 142,033
Top 17%
Country · Poland90,531 / 495,860
Top 18%
Results vs industry
Revenue
This companyUSD 1.77mMedianUSD 766.10kAverageUSD 2.40m
Net profit
This companyUSD 24.39kMedianUSD 38.62kAverageUSD 163.20k
Operating costs
This companyUSD 1.74mMedianUSD 680.10kAverageUSD 2.18m
Assets
This companyUSD 221.75kMedianUSD 261.25kAverageUSD 1.56m
Industry
Public procurement
11 tenders recorded as contractor, with a total value of $40,335,849.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 28, 2026 | Call for bids for the provision of healthcare services in cardiac surgery and transplantation at Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego Państwowy Instytut Badawczy w Warszawie, ul. Alpejska 42 | $3.1M$3,116,922 | Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy | |
| Aug 24, 2026 | Call for tenders for the provision of healthcare services in the field of electrophysiology and electrotherapy at Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy in Warszawa, at ul. Alpejska 42. | $3.3M$3,271,136 | Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy | |
| May 27, 2026 | Tender for the provision of healthcare services by anaesthesiologists in anaesthesiology and intensive care at Narodowy Instytut Kardiologii in Warszawa, ul. Alpejska 42 | $178.3K$178,282 | Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy |
Authorized Representatives
Adam Paweł Parulski – Management Board Member
Teresa Grzybek – President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Teresa Grzybekage 66 | 50 | $675.31 | 50% |
Adam Paweł Parulskiage 58 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zdrowa Rodzina Przychodnia Lekarska sp. z o.o.sp. k. | $1,902,122.02 | zdrowarodzina.waw.pl | ||
| DR Rothsp. z o.o. | $1,901,817.06 | drmartaroth.com | ||
| Radio Medicasp. z o.o. | $1,895,477.87 | radiomedica.pl | ||
| Kacdoktorsp. z o.o. | $1,725,454.16 | kacdoktor.pl | ||
| LUX Medsp. z o.o. | $1,296,555.15 | luxmed.pl | ||
| MKK Medica Małgorzata Krynicka - Kozak I Wojciech Kozaksp. k. | $1,329,243.61 | mkkmedica.pl | ||
| Przychodnia Rodzinna Piaskisp. z o.o. | $1,045,681.55 | przychodnia-piaski.pl | ||
| Medic Housesp. z o.o. | $784,821.03 | medichouse.pl | ||
| Instytut Ozonoterapii Salus – Medycyna Komplementarnasp. z o.o. | $635,945.76 | instytutozonoterapii.pl | ||
| E-Przychodnia24sp. z o.o. | $578,282.61 | e-przychodnia24.pl |
FAQ
The main business activity of Wierzbiny focuses on general medical practice activities.
The company was registered in the Polish National Court Register (KRS) on October 21, 2016.
The headquarters is located at: ul. Wierzbiny 8, 03-289 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
In 2021, the company generated total revenue of $1,769,878, representing an increase of 6332.2% compared to 2020.
Yes, the company recorded a net profit of $24,394 in 2021, meaning the company increased its profit by 70.0%.
The largest operating cost category falls under materials and energy. This category amounted to $6,047 in 2021, representing 0% of all operating expenses.
Last updated: 2026-04-20